GnRHa for Ovarian Protection and the Association Between AMH and Ovarian Function During Adjuvant Chemotherapy for Breast Cancer

Journal of Cancer - Australia
doi 10.7150/jca.31859
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Gonadotropin-Releasing Hormone Agonists for Ovarian Protection During Cancer Chemotherapy: Systematic Review and Meta-Analysis

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

AMH/MIS as a Contraceptive That Protects the Ovarian Reserve During Chemotherapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Changes in Ovarian Stromal Function and Associated Symptoms in Premenopausal Women Undergoing Chemotherapy for Breast Cancer

2008English

Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer

Journal of Peritoneum (and other serosal surfaces)
2017English

Association Between Ovarian Cancer and Advanced Endometriosis

Oncology Letters
Cancer ResearchOncology
2018English

The Association Between Talc Use and Ovarian Cancer

Epidemiology
Epidemiology
2016English

Association Between Interleukin‑33 and Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Adjuvant Chemotherapy for Early Breast Cancer.

BMJ
1983English

Protection of Ovarian Function by Oral Contraceptives in Women Receiving Chemotherapy for Hodgkin's Disease

Blood
BiochemistryImmunologyCell BiologyHematology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy